Figure 4.
JWH133 treatment inhibits the growth of glioma two weeks after implantation. Representative bioluminescent images (A) and the quantification (B) of the tumor-bearing mice implanted with U87 in the Control, U87, U87 + JWH133, U87 + JWH133 + AM630, and 11,12-EET groups. Data are shown as mean ± S.E.M, n = 5, **P < 0.01 vs. U87 group, ##P < 0.01 vs. U87 + JWH133 group (one-way ANOVA followed by Tukey’s post hoc test).